Alex Morozov long Elekta: London Value Investor Conference

We're posting notes from the London Value Investor Conference 2016.  Next up is Alex Morozov of Morningstar Equity Research who pitched long Elekta.


Alex Morozov's London Value Investor Conference Presentation

Investment idea: Elekta 

Elekta is a Sweden based company specialising in making radio therapy machines for patients with cancer. It’s not new technology but it is effective. Expect secular growth outside the US in radio therapy – 4-6% per year. Current guidelines call for radio therapy in 50% of cancer patients and the incidence of cancer is going up.

Elekta has a wide moat – there are two main players, Electa and Varian, that make radio therapy machines now that Siemens has exited the market.

Intangible assets: IP, brands, chemical databases, R&D productivity.

Switching costs: clinical relationships, there is a large installed base in large hospitals, re-training.  Aftermarket sales provide a lucrative revenue stream.

The share price has pulled back due to a slowdown in order growth, software issues, change of CEO, poor cash flow conversion. The company has been known to use aggressive accounting practices. R&D expenditure has been high.  Margins have bottomed and cash flow is improving. Valuation is attractive but patience will be required.



Be sure to check out the rest of the presentations from the London Value Investor Conference.

Morningstar Discount

Just wanted to pass along this discount for those of you interested. We just got word from their team that Morningstar has $20 off a one year subscription to their Premium membership. So, if you're a financial advisor or asset manager who uses those resources, here's a quick way to save some money. Or, if you're a retail investor looking for research resources, this is a great tool. You can also get a free 14 day trial if you want to check things out beforehand as well. Definitely worth a spin since it's free.


Don't forget to also check out the list of discounts on financial publications we've compiled. We've covered all the major financial news sources and some of the highlights include:

• 75% off the WSJ
• 40% discount on Barron's
• 60% off Investors Business Daily

Gotta love the discounts when newspapers are struggling.

Morningstar Newsletters: Free 30 Day Trials

Wanted to give our readers a heads up that Morningstar is now offering a brand new collection of various newsletters all with free 30 day trials on different topics including:

Different investment styles:

• Fund Investor
• Stock Investor
• Dividend Investor
• Options Investor
  
• Opportunistic Investor
• ETF Investor
• Practical Finance

And analysis on the various retirement fund choices, dependent on where your 401k assets are kept:

• Vanguard Fund Family
• Fidelity Fund Family
• American Fund Family
  

All the separate links above take you to the specific newsletter where you can get the 30 day free trial on each of them. These are great resources, especially for those of you with assets/401k's at the specific funds, as they can help you analyze your choices. Head on over there to check out each of the free offerings while you can since we don't know how long this promotion lasts. While you're there, make sure to utilize their great portfolio x-ray tool too.